Carvedilol increases plasma vascular endothelial growth factor (VEGF) in patients with chronic heart failure

Eur J Heart Fail. 2001 Jun;3(3):331-3. doi: 10.1016/s1388-9842(01)00129-5.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use*
  • Atrial Natriuretic Factor / drug effects
  • Blood Pressure / drug effects
  • Carbazoles / therapeutic use*
  • Carvedilol
  • Chronic Disease
  • Double-Blind Method
  • Endothelial Growth Factors / blood*
  • Female
  • Heart Failure / drug therapy*
  • Heart Rate / drug effects
  • Humans
  • Lymphokines / blood*
  • Lymphokines / drug effects*
  • Male
  • Middle Aged
  • Propanolamines / therapeutic use*
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Adrenergic beta-Antagonists
  • Carbazoles
  • Endothelial Growth Factors
  • Lymphokines
  • Propanolamines
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Carvedilol
  • Atrial Natriuretic Factor